Global Oral Contraceptive Market Research Report 2022

Global Oral Contraceptive Market Research Report 2022

Table of Contents
1 Oral Contraceptive Market Overview
1.1 Product Overview and Scope of Oral Contraceptive
1.2 Oral Contraceptive Segment by Type
1.2.1 Global Oral Contraceptive Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Combination
1.2.3 Progestin Only
1.2.4 Others
1.3 Oral Contraceptive Segment by Application
1.3.1 Global Oral Contraceptive Sales Comparison by Application: (2022-2028)
1.3.2 Male
1.3.3 Female
1.4 Global Oral Contraceptive Market Size Estimates and Forecasts
1.4.1 Global Oral Contraceptive Revenue 2017-2028
1.4.2 Global Oral Contraceptive Sales 2017-2028
1.4.3 Oral Contraceptive Market Size by Region: 2017 Versus 2021 Versus 2028
2 Oral Contraceptive Market Competition by Manufacturers
2.1 Global Oral Contraceptive Sales Market Share by Manufacturers (2017-2022)
2.2 Global Oral Contraceptive Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Oral Contraceptive Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Oral Contraceptive Manufacturing Sites, Area Served, Product Type
2.5 Oral Contraceptive Market Competitive Situation and Trends
2.5.1 Oral Contraceptive Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oral Contraceptive Players Market Share by Revenue
2.5.3 Global Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Contraceptive Retrospective Market Scenario by Region
3.1 Global Oral Contraceptive Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Oral Contraceptive Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Oral Contraceptive Market Facts & Figures by Country
3.3.1 North America Oral Contraceptive Sales by Country
3.3.2 North America Oral Contraceptive Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oral Contraceptive Market Facts & Figures by Country
3.4.1 Europe Oral Contraceptive Sales by Country
3.4.2 Europe Oral Contraceptive Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oral Contraceptive Market Facts & Figures by Region
3.5.1 Asia Pacific Oral Contraceptive Sales by Region
3.5.2 Asia Pacific Oral Contraceptive Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oral Contraceptive Market Facts & Figures by Country
3.6.1 Latin America Oral Contraceptive Sales by Country
3.6.2 Latin America Oral Contraceptive Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oral Contraceptive Market Facts & Figures by Country
3.7.1 Middle East and Africa Oral Contraceptive Sales by Country
3.7.2 Middle East and Africa Oral Contraceptive Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Oral Contraceptive Historic Market Analysis by Type
4.1 Global Oral Contraceptive Sales Market Share by Type (2017-2022)
4.2 Global Oral Contraceptive Revenue Market Share by Type (2017-2022)
4.3 Global Oral Contraceptive Price by Type (2017-2022)
5 Global Oral Contraceptive Historic Market Analysis by Application
5.1 Global Oral Contraceptive Sales Market Share by Application (2017-2022)
5.2 Global Oral Contraceptive Revenue Market Share by Application (2017-2022)
5.3 Global Oral Contraceptive Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer, Inc.
6.1.1 Pfizer, Inc. Corporation Information
6.1.2 Pfizer, Inc. Description and Business Overview
6.1.3 Pfizer, Inc. Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer, Inc. Oral Contraceptive Product Portfolio
6.1.5 Pfizer, Inc. Recent Developments/Updates
6.2 Bayer AG
6.2.1 Bayer AG Corporation Information
6.2.2 Bayer AG Description and Business Overview
6.2.3 Bayer AG Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Bayer AG Oral Contraceptive Product Portfolio
6.2.5 Bayer AG Recent Developments/Updates
6.3 Merck & Co., Inc.
6.3.1 Merck & Co., Inc. Corporation Information
6.3.2 Merck & Co., Inc. Description and Business Overview
6.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Merck & Co., Inc. Oral Contraceptive Product Portfolio
6.3.5 Merck & Co., Inc. Recent Developments/Updates
6.4 Janssen Global Services, LLC
6.4.1 Janssen Global Services, LLC Corporation Information
6.4.2 Janssen Global Services, LLC Description and Business Overview
6.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Janssen Global Services, LLC Oral Contraceptive Product Portfolio
6.4.5 Janssen Global Services, LLC Recent Developments/Updates
6.5 Mankind Pharma Ltd.
6.5.1 Mankind Pharma Ltd. Corporation Information
6.5.2 Mankind Pharma Ltd. Description and Business Overview
6.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Mankind Pharma Ltd. Oral Contraceptive Product Portfolio
6.5.5 Mankind Pharma Ltd. Recent Developments/Updates
6.6 Teva Pharmaceutical Industries Ltd
6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Portfolio
6.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.7 Allergan, plc (Actavis)
6.6.1 Allergan, plc (Actavis) Corporation Information
6.6.2 Allergan, plc (Actavis) Description and Business Overview
6.6.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Allergan, plc (Actavis) Oral Contraceptive Product Portfolio
6.7.5 Allergan, plc (Actavis) Recent Developments/Updates
6.8 Piramal Enterprises Ltd.
6.8.1 Piramal Enterprises Ltd. Corporation Information
6.8.2 Piramal Enterprises Ltd. Description and Business Overview
6.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Piramal Enterprises Ltd. Oral Contraceptive Product Portfolio
6.8.5 Piramal Enterprises Ltd. Recent Developments/Updates
6.9 Beijing Zizhu Pharm
6.9.1 Beijing Zizhu Pharm Corporation Information
6.9.2 Beijing Zizhu Pharm Description and Business Overview
6.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Beijing Zizhu Pharm Oral Contraceptive Product Portfolio
6.9.5 Beijing Zizhu Pharm Recent Developments/Updates
7 Oral Contraceptive Manufacturing Cost Analysis
7.1 Oral Contraceptive Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oral Contraceptive
7.4 Oral Contraceptive Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oral Contraceptive Distributors List
8.3 Oral Contraceptive Customers
9 Oral Contraceptive Market Dynamics
9.1 Oral Contraceptive Industry Trends
9.2 Oral Contraceptive Market Drivers
9.3 Oral Contraceptive Market Challenges
9.4 Oral Contraceptive Market Restraints
10 Global Market Forecast
10.1 Oral Contraceptive Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oral Contraceptive by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Oral Contraceptive by Type (2023-2028)
10.2 Oral Contraceptive Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oral Contraceptive by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Oral Contraceptive by Application (2023-2028)
10.3 Oral Contraceptive Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oral Contraceptive by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Oral Contraceptive by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Oral Contraceptive Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Oral Contraceptive Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Oral Contraceptive Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Oral Contraceptive Market Competitive Situation by Manufacturers in 2021
Table 5. Global Oral Contraceptive Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Oral Contraceptive Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Oral Contraceptive Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Oral Contraceptive Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Oral Contraceptive Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Oral Contraceptive Manufacturing Sites and Area Served
Table 11. Manufacturers Oral Contraceptive Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oral Contraceptive by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Contraceptive as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Oral Contraceptive Sales by Region (2017-2022) & (K Units)
Table 16. Global Oral Contraceptive Sales Market Share by Region (2017-2022)
Table 17. Global Oral Contraceptive Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Oral Contraceptive Revenue Market Share by Region (2017-2022)
Table 19. North America Oral Contraceptive Sales by Country (2017-2022) & (K Units)
Table 20. North America Oral Contraceptive Sales Market Share by Country (2017-2022)
Table 21. North America Oral Contraceptive Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Oral Contraceptive Revenue Market Share by Country (2017-2022)
Table 23. Europe Oral Contraceptive Sales by Country (2017-2022) & (K Units)
Table 24. Europe Oral Contraceptive Sales Market Share by Country (2017-2022)
Table 25. Europe Oral Contraceptive Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Oral Contraceptive Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Oral Contraceptive Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Oral Contraceptive Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Oral Contraceptive Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Oral Contraceptive Revenue Market Share by Region (2017-2022)
Table 31. Latin America Oral Contraceptive Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Oral Contraceptive Sales Market Share by Country (2017-2022)
Table 33. Latin America Oral Contraceptive Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Oral Contraceptive Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Oral Contraceptive Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Oral Contraceptive Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Oral Contraceptive Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Oral Contraceptive Revenue Market Share by Country (2017-2022)
Table 39. Global Oral Contraceptive Sales by Type (2017-2022) & (K Units)
Table 40. Global Oral Contraceptive Sales Market Share by Type (2017-2022)
Table 41. Global Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Oral Contraceptive Revenue Share by Type (2017-2022)
Table 43. Global Oral Contraceptive Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Oral Contraceptive Sales (K Units) by Application (2017-2022)
Table 45. Global Oral Contraceptive Sales Market Share by Application (2017-2022)
Table 46. Global Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Oral Contraceptive Revenue Share by Application (2017-2022)
Table 48. Global Oral Contraceptive Price by Application (2017-2022) & (USD/Unit)
Table 49. Pfizer, Inc. Corporation Information
Table 50. Pfizer, Inc. Description and Business Overview
Table 51. Pfizer, Inc. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer, Inc. Oral Contraceptive Product
Table 53. Pfizer, Inc. Recent Developments/Updates
Table 54. Bayer AG Corporation Information
Table 55. Bayer AG Description and Business Overview
Table 56. Bayer AG Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Bayer AG Oral Contraceptive Product
Table 58. Bayer AG Recent Developments/Updates
Table 59. Merck & Co., Inc. Corporation Information
Table 60. Merck & Co., Inc. Description and Business Overview
Table 61. Merck & Co., Inc. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Merck & Co., Inc. Oral Contraceptive Product
Table 63. Merck & Co., Inc. Recent Developments/Updates
Table 64. Janssen Global Services, LLC Corporation Information
Table 65. Janssen Global Services, LLC Description and Business Overview
Table 66. Janssen Global Services, LLC Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Janssen Global Services, LLC Oral Contraceptive Product
Table 68. Janssen Global Services, LLC Recent Developments/Updates
Table 69. Mankind Pharma Ltd. Corporation Information
Table 70. Mankind Pharma Ltd. Description and Business Overview
Table 71. Mankind Pharma Ltd. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Mankind Pharma Ltd. Oral Contraceptive Product
Table 73. Mankind Pharma Ltd. Recent Developments/Updates
Table 74. Teva Pharmaceutical Industries Ltd Corporation Information
Table 75. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 76. Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Teva Pharmaceutical Industries Ltd Oral Contraceptive Product
Table 78. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 79. Allergan, plc (Actavis) Corporation Information
Table 80. Allergan, plc (Actavis) Description and Business Overview
Table 81. Allergan, plc (Actavis) Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Allergan, plc (Actavis) Oral Contraceptive Product
Table 83. Allergan, plc (Actavis) Recent Developments/Updates
Table 84. Piramal Enterprises Ltd. Corporation Information
Table 85. Piramal Enterprises Ltd. Description and Business Overview
Table 86. Piramal Enterprises Ltd. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Piramal Enterprises Ltd. Oral Contraceptive Product
Table 88. Piramal Enterprises Ltd. Recent Developments/Updates
Table 89. Beijing Zizhu Pharm Corporation Information
Table 90. Beijing Zizhu Pharm Description and Business Overview
Table 91. Beijing Zizhu Pharm Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Beijing Zizhu Pharm Oral Contraceptive Product
Table 93. Beijing Zizhu Pharm Recent Developments/Updates
Table 94. Production Base and Market Concentration Rate of Raw Material
Table 95. Key Suppliers of Raw Materials
Table 96. Oral Contraceptive Distributors List
Table 97. Oral Contraceptive Customers List
Table 98. Oral Contraceptive Market Trends
Table 99. Oral Contraceptive Market Drivers
Table 100. Oral Contraceptive Market Challenges
Table 101. Oral Contraceptive Market Restraints
Table 102. Global Oral Contraceptive Sales Forecast by Type (2023-2028) & (K Units)
Table 103. Global Oral Contraceptive Sales Market Share Forecast by Type (2023-2028)
Table 104. Global Oral Contraceptive Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 105. Global Oral Contraceptive Revenue Market Share Forecast by Type (2023-2028)
Table 106. Global Oral Contraceptive Sales Forecast by Application (2023-2028) & (K Units)
Table 107. Global Oral Contraceptive Sales Market Share Forecast by Application (2023-2028)
Table 108. Global Oral Contraceptive Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 109. Global Oral Contraceptive Revenue Market Share Forecast by Application (2023-2028)
Table 110. Global Oral Contraceptive Sales Forecast by Region (2023-2028) & (K Units)
Table 111. Global Oral Contraceptive Sales Market Share Forecast by Region (2023-2028)
Table 112. Global Oral Contraceptive Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 113. Global Oral Contraceptive Revenue Market Share Forecast by Region (2023-2028)
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Contraceptive
Figure 2. Global Oral Contraceptive Market Share by Type in 2021 & 2028
Figure 3. Combination Product Picture
Figure 4. Progestin Only Product Picture
Figure 5. Others Product Picture
Figure 6. Global Oral Contraceptive Market Share by Application in 2021 & 2028
Figure 7. Male
Figure 8. Female
Figure 9. Global Oral Contraceptive Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Oral Contraceptive Market Size (2017-2028) & (US$ Million)
Figure 11. Global Oral Contraceptive Sales (2017-2028) & (K Units)
Figure 12. Oral Contraceptive Sales Share by Manufacturers in 2021
Figure 13. Global Oral Contraceptive Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Oral Contraceptive Players: Market Share by Revenue in 2021
Figure 15. Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Oral Contraceptive Sales Market Share by Region (2017-2022)
Figure 17. Global Oral Contraceptive Sales Market Share by Region in 2021
Figure 18. Global Oral Contraceptive Revenue Market Share by Region (2017-2022)
Figure 19. Global Oral Contraceptive Revenue Market Share by Region in 2021
Figure 20. U.S. Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Taiwan Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Philippines Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Vietnam Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Oral Contraceptive Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Oral Contraceptive by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Oral Contraceptive
Figure 46. Manufacturing Process Analysis of Oral Contraceptive
Figure 47. Oral Contraceptive Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119

According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......

Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......

Global Contraceptives Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141

According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......

Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108

According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......

Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......

Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139

Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......

Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122

Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......

Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108

Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......

Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs